117 related articles for article (PubMed ID: 8421100)
1. Hypoaldosteronism accompanied by normal or elevated mineralocorticosteroid pathway steroid: a marker of adrenal carcinoma.
Aupetit-Faisant B; Battaglia C; Zenatti M; Emeric-Blanchouin N; Legrand JC
J Clin Endocrinol Metab; 1993 Jan; 76(1):38-43. PubMed ID: 8421100
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of aldosterone versus aldosterone precursors: a way to estimate the malignancy of asymptomatic and nonsecretory adrenal tumors: a French Retrospective Multicentric Study.
Aupetit-Faisant B; Blanchouin-Emeric N; Tenenbaum F; Battaglia C; Tabarin A; Amar J; Kuttenn F; Warnet A; Assayag M; Chamontin B
J Clin Endocrinol Metab; 1995 Sep; 80(9):2715-21. PubMed ID: 7673414
[TBL] [Abstract][Full Text] [Related]
3. Paper chromatographic systems for the separation of aldosterone, 18-hydroxycorticosterone, 18-hydroxydeoxycorticosterone, corticosterone and deoxycorticosterone.
Witzgall H; Hassan-Ali S
J Chromatogr; 1980 Sep; 198(1):70-5. PubMed ID: 7430313
[TBL] [Abstract][Full Text] [Related]
4. The zonal origins of the mineralocorticoid hormones in the 21-hydroxylation deficiency of congenital adrenal hyperplasia.
Biglieri EG; Wajchenberg BL; Malerbi DA; Okada H; Leme CE; Kater CE
J Clin Endocrinol Metab; 1981 Nov; 53(5):964-9. PubMed ID: 6270186
[TBL] [Abstract][Full Text] [Related]
5. Plasma 18-hydroxycorticosterone and aldosterone responses to angiotensin II and corticotropin in diabetic patients with hyporeninemic and normoreninemic hypoaldosteronism.
Iwasaki R; Kigoshi T; Uchida K; Morimoto S
Acta Endocrinol (Copenh); 1989 Jul; 121(1):83-9. PubMed ID: 2545066
[TBL] [Abstract][Full Text] [Related]
6. Distinctive plasma aldosterone, 18-hydroxycorticosterone, and 18-hydroxydeoxycorticosterone profile in the 21-, 17 alpha-, and 11 beta-hydroxylase deficiency types of congenital adrenal hyperplasia.
Kater CE; Biglieri EG
Am J Med; 1983 Jul; 75(1):43-8. PubMed ID: 6602548
[TBL] [Abstract][Full Text] [Related]
7. The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
Biglieri EG; Kater CE; Brust N; Chang B; Hirai J
Clin Exp Hypertens A; 1982; 4(9-10):1677-83. PubMed ID: 7139973
[TBL] [Abstract][Full Text] [Related]
8. Impaired mineralocorticoid hormone responses to adrenocorticotropin stimulation: additional characterization of heterozygosity for the 21-hydroxylase deficiency type of congenital adrenal hyperplasia.
Pardini DP; Kater CE; Vieira JG; Biglieri EG
J Clin Endocrinol Metab; 1983 Nov; 57(5):1061-6. PubMed ID: 6311859
[TBL] [Abstract][Full Text] [Related]
9. [Strategy for studying mineralocorticoids other than aldosterone in arterial hypertension of hormonal origin].
Roger M; Nahoul K; Laloy E; Scholler R
Ann Med Interne (Paris); 1983; 134(3):238-41. PubMed ID: 6625419
[TBL] [Abstract][Full Text] [Related]
10. A simultaneous radioimmunoassay for aldosterone and its precursors: human plasma levels following the inhibition of converting enzyme, before and after blockade of prostaglandin biosynthesis.
Witzgall H; Hassan-Ali S
J Clin Chem Clin Biochem; 1981 Jun; 19(6):387-94. PubMed ID: 6268734
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone and other mineralocorticoids in Bartter's syndrome.
Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
[TBL] [Abstract][Full Text] [Related]
12. 17 alpha-hydroxylase deficiency: mineralocorticoid hormone profiles in an affected family.
D'Armiento M; Reda G; Kater C; Shackleton CH; Biglieri EG
J Clin Endocrinol Metab; 1983 Apr; 56(4):697-701. PubMed ID: 6300162
[TBL] [Abstract][Full Text] [Related]
13. Effects of continued adrenocorticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical simple virilizing types of 21-hydroxylase deficiency.
Kater CE; Biglieri EG; Wajchenberg B
J Clin Endocrinol Metab; 1985 Jun; 60(6):1057-62. PubMed ID: 2987285
[TBL] [Abstract][Full Text] [Related]
14. Adrenal adenoma with 18-hydroxycorticosterone excess and hypertension: a variant of aldosteronomas.
Kigoshi T; Imaizumi N; Azukizawa S; Yamamoto I; Hosojima H; Uchida K; Morimoto S
Horm Res; 1984; 19(4):224-31. PubMed ID: 6745843
[TBL] [Abstract][Full Text] [Related]
15. The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels.
Kem DC; Tang K; Hanson CS; Brown RD; Painton R; Weinberger MH; Hollifield JW
J Clin Endocrinol Metab; 1985 Jan; 60(1):67-73. PubMed ID: 3964794
[TBL] [Abstract][Full Text] [Related]
16. Adrenocorticotropin inhibition of mineralocorticoid hormone production.
Biglieri EG; Chang B; Hirai J; Brust N; Rost CR; Schambelan M
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():307s-311s. PubMed ID: 232023
[TBL] [Abstract][Full Text] [Related]
17. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism.
Guthrie GP
J Lab Clin Med; 1981 Sep; 98(3):364-73. PubMed ID: 6267148
[TBL] [Abstract][Full Text] [Related]
18. Hyperreninemic hypoaldosteronism due to hepatocellular carcinoma metastatic to the adrenal gland.
Otabe S; Muto S; Asano Y; Sato K; Ohtani M; Kawamoto C; Ido K; Kimura K
Clin Nephrol; 1991 Feb; 35(2):66-71. PubMed ID: 1850333
[TBL] [Abstract][Full Text] [Related]
19. [Dysfunction of the aldosterone synthesis pathway as a marker of malignity in symptomatic and asymptomatic adrenal masses].
Aupetit-Faisant B; Blanchouin N; Legrand JC
Bull Acad Natl Med; 1995 Oct; 179(7):1355-65; discussion 1365-7. PubMed ID: 8556410
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms establishing the mineralocorticoid hormone patterns in the 17 alpha-hydroxylase deficiency syndrome.
Biglieri EG
J Steroid Biochem; 1979 Jul; 11(1B):653-7. PubMed ID: 226795
[No Abstract] [Full Text] [Related]
[Next] [New Search]
